HCP Universe
2.2M
Verified NPIs in EQ5 datagraph
NPI Match Rate
90%++
vs. 40–60% industry standard
Program Options
3 Tiers
Pilot to full multi-channel program
Specialty Focus
Rare Disease
Neuromuscular / NMD · 48-hr launch
Audience Architecture
NPI Match Rate
90%++
Industry avg 40–60% for rare disease
HCP NPI Datagraph
2.2M
Covers all NMD specialty HCPs nationally
Launch Time
48 hrs
From signed IO to first impressions
Audience Segments & NMD Specialist Coverage
Dyne’s prescriber universe segmented by specialty and funnel role
Segment Funnel Stage HCP Type EQ5 Channel
Segment 1
NMD Core Specialists
Consideration Neuromuscular specialists · neurologists with NMD caseloads · Dyne NPI target list Programmatic Display + LinkedIn + Meta
Segment 2
General Neurology
Awareness General neurologists · physiatrists · rare disease center physicians Programmatic Display + Meta
Segment 3
Care Team
Awareness APPs · genetic counselors · patient identification & referral pathway LinkedIn + Meta
Channels
HCP Programmatic Display
$185 CPM all-in · Deterministic NPI matching
200+ premium medical publishers · Segments 1 & 2
LinkedIn HCP Targeting
NPI-matched professional context
Neuromuscular specialists · Rare disease KOLs · Segment 1
Meta (Facebook / Instagram)
NPI-matched social reach driver
All segments · Highest HCP impression volume · Mobile-first
Full Funnel Analytics
Physician-level reporting · sFTP delivery
NPI-level engagement scoring · CRM integration · No extra cost
Newsletter / Publisher Ads
Trusted clinical context
Neurology & rare disease specialty publications
Engagement Scoring
5-tier HCP scoring from Day 1
Cold → Aware → Warm → Hot Lead → Field Ready
Investment Options
Starter — Proof of Concept
Pilot Program
3 months · Core programmatic + 1 social
$50K–$100K
Duration3 months
ChannelsProgrammatic + LinkedIn
SegmentsSegment 1 (NMD core)
ReportingWeekly sFTP + NPI report
Engagement ScoringIncluded
Best for: Proof-of-concept · Validate match rate before full commitment
Scale — Full Program
Full Year Multi-Channel
12 months · All channels + Account Management
$250K–$300K
Duration12 months
All Growth channels + Account Mgmt + Optimization
SegmentsAll segments + full care team
ReportingWeekly + monthly deep dive
Engagement ScoringFull 5-tier + field activation
Best for: Full launch year · Maximum prescriber reach · Field data integration
Pricing Model — $185 CPM All-In
One transparent CPM covers creative serving, data, reporting, and all platform fees. No hidden technology markups. All tiers include NPI-level physician reporting, engagement scoring, and weekly sFTP delivery. For rare disease where total specialist universe may be under 5,000 HCPs, EQ5’s 90%++ match rate means near-complete prescriber coverage — something no other vendor can match at this price point.
Next Steps — Pipeline Conversion
Conversion Roadmap
Dyne Therapeutics · Owner: Lee Slovitt · Org ID 4100
In Pipeline
1
Free NPI List Match Analysis
Request Dyne NPI prescriber list · run EQ5’s 90%++ match analysis against 2.2M NPI datagraph · deliver match report at no cost within 24 hours of receipt
2
Proof-of-Concept Pilot Proposal
3-month pilot $50K–$100K · measurable outcomes with physician-level NPI reporting · 48-hour launch from signed IO · present Starter tier to Catherine Collard & Michael Hencke
3
Full Multi-Channel Program
Scale to Growth or Scale tier · programmatic + social + publisher · full funnel analytics + cross-channel sequencing + engagement scoring with field activation data
Immediate action → Request Dyne NPI list from Catherine Collard or Michael Hencke (mhencke@dyne-tx.com)
Ready to run the free match analysis?
Submit Dyne’s NPI target list and EQ5 delivers a free match analysis within 24 hours — confirming HCP coverage across programmatic, LinkedIn, and Meta before any IO is signed. Zero-risk first step to a pilot.
Contact Lee Slovitt (SVP, Media & Platform Partnerships)  ·  lee@equals5.com
StatusIn Pipeline
RepLee Slovitt
Org ID4100
Since2026
FocusRare Disease / Neuromuscular
StatusProposal in development